Stay updated on Switch to Dolutegravir + Rilpivirine Clinical Trial

Sign up to get notified when there's something new on the Switch to Dolutegravir + Rilpivirine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Switch to Dolutegravir + Rilpivirine Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    Change Detected
    Summary
    The study has expanded to 65 locations and has been updated from revision v2.9.7 to v2.10.0.
    Difference
    0.1%
    Check dated 2024-07-23T15:44:03.000Z thumbnail image
  5. Check
    4 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.0%
    Check dated 2024-07-16T09:01:21.000Z thumbnail image
  7. Check
    18 days ago
    Change Detected
    Summary
    A new erratum was published in the Lancet on June 16, 2018, regarding the study on dolutegravir-rilpivirine for maintaining virological suppression in adults with HIV-1.
    Difference
    0.1%
    Check dated 2024-07-08T23:09:14.000Z thumbnail image
  8. Check
    24 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6. This change represents an update in the study details and results of the clinical trial evaluating the efficacy, safety, and tolerability of switching to Dolutegravir plus Rilpivirine from current antiretroviral regimens in HIV-1-infected adults.
    Difference
    0.0%
    Check dated 2024-07-02T15:21:50.000Z thumbnail image
  9. Check
    30 days ago
    Change Detected
    Summary
    The value Revision: v2.9.3 has recently changed to Revision: v2.9.5. This change represents an update in the study record details and results of the clinical trial involving the switch to Dolutegravir + Rilpivirine from current antiretroviral regimens in HIV-1 infected adults.
    Difference
    0.0%
    Check dated 2024-06-27T10:50:15.000Z thumbnail image
  10. Check
    31 days ago
    Change Detected
    Summary
    The value Revision: v2.9.1 has recently changed to Revision: v2.9.3. This change represents an update in the study record details and results of the clinical trial involving the switch to Dolutegravir + Rilpivirine from current antiretroviral regimens in HIV-1 infected adults.
    Difference
    0.0%
    Check dated 2024-06-26T09:43:27.000Z thumbnail image

Stay in the know with updates to Switch to Dolutegravir + Rilpivirine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Switch to Dolutegravir + Rilpivirine Clinical Trial page.